RS

Ravi Sujatha

Active Director Director DIN 08839376
DIN 08839376 First appointment Aug 2020 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravi Sujatha

Data last updated:

Ravi Sujatha is a Director at Sushrutha Chempharma Private Limited (since 2020). The company operates in Chemicals and Materials.

DIN 08839376
Primary Designation Director
Industry Chemicals and Materials
First Appointment 19 Aug 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sushrutha Chempharma Private Limited U24231TG2020PTC142968
Director19 Aug 20202020Active

Board colleagues of Ravi Sujatha

Directorship timeline

Open interactive timeline →
Sushrutha Chempharma Private Limited
Premium access

Shareholding and investment profile for Ravi Sujatha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Sujatha

Ravi Sujatha currently holds 1 directorship: Sushrutha Chempharma Private Limited (Director, since 19 Aug 2020).

Ravi Sujatha was first appointed on 19 Aug 2020 as Director at Sushrutha Chempharma Private Limited.

The current boards of Ravi Sujatha's companies include Alluru Ashokreddy (Sushrutha Chempharma Private Limited), Narasimha Reddy Enukonda (Sushrutha Chempharma Private Limited), Payyavula Jayachandrika (Sushrutha Chempharma Private Limited), Rajani Nuthanapati (Sushrutha Chempharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available